|
Patient activation measures, distress levels, and causes of distress in chronic lymphocytic leukemia. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Alexion Pharmaceuticals |
Speakers' Bureau - Novartis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Catalyst Pharmaceuticals; Idera |
|
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - DiaDexus |
Research Funding - Amgen (Inst) |
|
|
|
Research Funding - Carevive Systems; Medscape; Pack Health |
Travel, Accommodations, Expenses - Medscape |